Paul W. Abramowitz is the Chief Executive Officer of the American Society of Health-System Pharmacists (ASHP).
Prior to joining ASHP in September 2011, Dr. Abramowitz worked in practice and leadership positions in hospitals and health-systems for 34 years. He received a BS in pharmacy from the University of Toledo, a PharmD from the University of Michigan, and completed his residency at the University of Michigan Medical Center.
In addition to serving as Treasurer of ASHP from 2007-2010 and ASHP President in 1993-1994, he chaired the Board of the ASHP Research and Education Foundation, the Iowa Board of Pharmacy, and the Iowa Statewide Poison Control Center.
Abramowitz has actively combined practice, teaching, and research throughout his career. He has lectured and published extensively focusing on the effect that quality pharmacy care can have on improving outcomes of care and reducing costs, developing new care models, reducing adverse drug events, and expanding comprehensive pharmacy care to the ambulatory setting.
He was a recipient of the John W. Webb Lecture Award in 2000 and the Harvey A.K. Whitney Lecture Award in 2009, health-system pharmacy’s highest honor. In 1990, he received the Distinguished Alumni Award from the University of Toledo College of Pharmacy, in 2010, the Alumni Distinguished Lifetime Achievement Award from the University of Michigan College of Pharmacy, and in 2013 the Honorary Degree of Doctor of Science from the University of Toledo. In 2015, he was recognized as one of Washington’s Trending Association Leaders by Bisnow.
In addition to serving on the PTCB Board of Governors, he serves on the Boards of the American Nurses Foundation, the GTMRx Institute, and the National Steering Committee for Patient Safety of the Institute for Healthcare Improvement. He is a Professor-Emeritus at the University of Iowa.